1427 companies · 1448 sector slots · 20 sectors · 22 below Rs1000cr and not scanned · long-term lens
Trend Spotlight
Supreme Court escalates hospital-pharmacy margin scrutiny, proposing a uniform cap on all medicines
At a Sept 29 hearing the Court called a cancer-drug markup of roughly 10x supply cost 'carnage' and asked government to evaluate extending the existing 16% trade-margin cap -- currently limited mostly to scheduled drugs -- to all medicines, also questioning hospitals' captive in-house pharmacy requirements. Hospital stocks sold off sharply (Apollo Hospitals -5.7%, Fortis -6.3%, Max Healthcare -5.3%, roughly Rs 248bn wiped off the BSE Hospitals Index) -- the clearest sign yet that pharmacy-markup economics, a real profit line for corporate hospital chains, face genuine multi-year regulatory risk rather than a one-day sentiment dip. A further hearing is set for Oct 12; nothing has been notified yet.
▲ 1903 advancing■ 33 unchanged▼ 734 decliningof 2670 equities, vs the 2026-10-05 close
Cash market, ₹ crore
FII / FPI net
▼ -2,961.30
bought 11,259 · sold 14,220
DII net
▲ +5,088.92
bought 20,146 · sold 15,057
FII / FPI
DII
Source: NSE ind_close_all_20261006
(levels, index P/E and P/B) and the full-market bhavcopy (breadth).
Index P/E from NSE's official daily index file.
Sector performance
This session's index move, next to the desk's standing stance. The stance
is a valuation-and-quality reading over years — it does not move because an index had
a good day. Sectors with no listed NSE index show — for the session columns; the stance still applies.
Set aside as undetermined: BLSE (▼ -49.58%). A move this
large over one session is usually a bonus, split or demerger rather than a price
change, and a close-only series cannot tell the two apart — so it is neither listed
as a mover nor quietly dropped.
Calls this session
A change to anything but AVOID publishes only after two consecutive
sessions say the same thing; AVOID publishes at once.
Good business, bad price today (Value 1/5) — PEG 7.83; P/E cheaper than 24% of sector peers (P/E 50.89); EV/EBITDA 25.8, B/M 0.172. Watch for a better entry.
Good business, bad price today (Value 2/5) — PEG 2.73; P/E cheaper than 37% of sector peers (P/E 37.71); EV/EBITDA 19.6, B/M 0.188. Watch for a better entry.
Good business, bad price today (Value 1/5) — PEG 1.19; P/E cheaper than 30% of sector peers (P/E 38.37); EV/EBITDA 108.7, B/M 0.276. Watch for a better entry.
Supreme Court proposes extending 16% margin cap to all medicines; hospital stocks sell off Healthcare & Hospitals
The Court called a cancer-drug markup of roughly 10x supply cost 'carnage' and asked government to evaluate extending the existing 16% trade-margin cap to all medicines, also questioning hospitals' captive in-house pharmacy requirements. The BSE Hospitals Index fell about 5% (~Rs 248bn wiped out), with Apollo Hospitals -5.7%, Fortis -6.3% and Max Healthcare -5.3%. The matter returns to court on Oct 12; no rule has been notified yet.
SMC Global and 5paisa surge on a broad capital-markets volume rally Financial Services
SMC Global Securities hit a fresh 52-week high on heavy turnover while 5paisa Capital locked at its 20% upper circuit with delivery volumes up 237% versus the 5-day average -- evidence of genuine accumulation, not pure speculation. Both were already flagged among the day's top sector movers; the rally reflects broad brokerage/capital-markets strength rather than stock-specific news.
Tyre and component makers line up ~Rs 18,000cr of capacity capex through FY28 Automobiles
Crisil expects JK Tyre and Apollo Tyres to spend roughly Rs 18,000 crore combined over FY27-28 on capacity expansion as demand for larger vehicles and new powertrains runs some plants near their limits; JK Tyre says it has had to forgo export orders to prioritize domestic supply. JK Fenner also entered a components partnership with Japan's Yamada Manufacturing, and Tube Investments will put Rs 250cr into EV subsidiary TI Clean Mobility.
Apollo Tyres CFO Gaurav Kumar resigns after 22 years, no successor named Automobiles
Kumar's resignation is effective close of business Oct 6, 2026; the exchange filing cites a move to pursue new opportunities and names no successor or transition plan. The departure follows MarketsMojo's late-August cut from Hold to Sell, even as Q1 FY27 net profit rose to Rs 349cr.
Hero MotoCorp CFO reiterates double-digit growth expectation for next fiscal Automobiles
CFO Vivek Anand said management expects a repeat of double-digit revenue growth next fiscal, backed by investment in premium and EV segments; September dispatches rose 12% YoY to 766,348 units and EV capacity is planned to triple to 45,000 units/month by fiscal year-end. This is management's own (single-sourced) guidance and runs counter to the pending BUY->HOLD downgrade rationale.
Entry score is 40% cheap-vs-history + 25% quality trend + 20% news catalyst + 15% technicals, for the 6 sectors with a researched catalyst. The other 14 show —: no catalyst was researched for them, so their score renormalises over the remaining three inputs rather than assuming a neutral headline. ≥62 accumulate · 45–61 watch · <45 avoid.
Source: data/verdicts.json × NSE sector index closes.
Stocks to Watch
Split evenly across large/mid/small/micro cap so this list isn't one
tier's picks — new calls first, then the highest long-term composites within each.
Micro-cap names are boxed and flagged Highly Volatile — worth
watching, not a call to buy — since their price swings run about twice every other
tier's. Each card shows the figures that selected it — open the desk for the full
six-lens panel.
ROCE 36.5% (down 3.5pt over 5y) · -34.7% off its 52-week high
Composite 69.9Mkt Cap 1,019 cr · MicroP/E 15.89ROCE 36.5%Piotroski 3/8
Lens Weights Recalibrated
Every Sunday, each lens's weight is re-tilted from its prior on
all evidence to date of whether its ratings predicted subsequent returns, measured
separately within each cap tier (data/lens_ic.json). Thin evidence moves a weight
a little, a consistent edge more -- see METHODOLOGY.md. Every past change stays
on the record in data/lens_weight_changes.json.
Tier
Lens
Weight
t-stat
Hit rate
Weeks measured
Large
Quality
1.5 → 1.4091
-0.2436
56%
7.2
Large
Financial Health
1.5 → 1.979
1.5119
69%
7.2
Large
Value
1.2 → 1.1404
-0.1992
50%
7.2
Large
Earnings Quality
1.0 → 1.2998
1.385
72%
7.2
Large
Growth Outlook
0.8 → 0.861
0.3075
53%
3.4
Large
Momentum
0.5 → 0.6138
0.9823
72%
7.2
Mid
Quality
1.5 → 1.3032
-0.5374
58%
7.2
Mid
Financial Health
1.5 → 1.8378
0.9703
61%
7.2
Mid
Value
1.2 → 1.113
-0.292
64%
7.2
Mid
Earnings Quality
1.0 → 0.9049
-0.3851
56%
7.2
Mid
Growth Outlook
0.8 → 0.7399
-0.3027
50%
0.4
Mid
Momentum
0.5 → 0.6691
1.6455
72%
7.2
Small
Quality
1.5 → 1.8524
1.0197
63%
5.4
Small
Financial Health
1.5 → 1.7831
0.7942
56%
5.4
Small
Value
1.2 → 1.1041
-0.3224
56%
5.4
Small
Earnings Quality
1.0 → 0.8708
-0.5286
52%
5.4
Small
Growth Outlook
0.8 → 1.0057
1.137
89%
1.8
Small
Momentum
0.5 → 0.6938
2.0669
74%
5.4
Micro
Quality
1.5 → 1.9052
1.2092
74%
5.4
Micro
Financial Health
1.5 → 1.7684
0.7489
59%
5.4
Micro
Value
1.2 → 1.0792
-0.4084
56%
5.4
Micro
Earnings Quality
1.0 → 1.0287
0.115
56%
5.4
Micro
Growth Outlook
0.8 → 0.7073
-0.4723
69%
2.6
Micro
Momentum
0.5 → 0.7238
2.894
93%
5.4
How We Evaluate
Metric
Why it is in the framework
Source
Return on capital, level and trend
Durable high ROCE predicts future returns; the trend separates a moat from a good year
Novy-Marx 2013 JFE
Gross profitability (GP/assets)
As predictive as book-to-market, and less prone to the value trap
Novy-Marx 2013 JFE
Piotroski F-score
A nine-signal accounting checklist that separates real improvers from statistically cheap traps